This page is part of our 2024 average annual return archive: it shows the GILD stock yearly return for calendar year 2024. This metric helps investors evaluate and compare performance among different stocks, over time.
Average annual return should be reviewed alongside overall market trends, and company fundamentals like earnings and revenue. As the saying goes on Wall St., past performance from 2024 does not guarantee future similar returns.
| GILD Stock Yearly Return 2024 Table | |||||||||||||||||||||||||||||||||
GILD average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare GILD average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| GILD Share Performance |
| GILD Stock Yearly Return 2024 Chart | |||
Also see: • GILD YTD return • GILD average annual return 10 years | |||
| About Gilead Sciences Inc |
| Gilead Sciences is a biopharmaceutical company focused on advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Co. emphasizes the discovery, development, and commercialization of medicines for unmet medical needs. Its marketed products include AmBisome, Atripla, Biktarvy, Descovy (including for PrEP), Epclusa, Genvoya, Harvoni, Sovaldi, Truvada (including for PrEP), Veklury, Vemlidy, Viread, Yescarta, and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Domvanalimab, Zimberelimab, and Seladelpar for treating primary biliary cholangitis (PBC). Co. operates in over 35 countries. The GILD stock yearly return is shown above.
The yearly return on the GILD stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2024 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the GILD annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| GILD Current Stock Quote |
 Free GILD Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Gilead Sciences (GILD) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
GKOS Average Annual Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.
Video: Don't Forget Dividends in Average Annual Return!